Feed AMRX
AM

Amneal Pharmaceuticals

AMRX · NASDAQ

$18.08 +8.59% (+$1.43)
1M -0.60%
Market Cap $5.77B
P/E Ratio 36.69x
Div. Yield -
ROE -

Bulios Fair Price

$12.75

29.5% downside

Trenutna cena

$18.08

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica AMRX trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
7/9
Valuation
28 /100
Expensive
P/E 36.69x
EV/EBITDA 12.94x
P/FCF 69.47x
Growth
70 /100
Growing
Rev. growth 10.92%
EPS growth N/A
FCF growth N/A
Profitability
46 /100
Moderate
Gross margin 39.32%
Net margin 5.05%
FCF margin 2.67%
Quality
67 /100
Excellent
ROIC 14.32%
ROA 4.17%
Asset turnover 0.83x
Debt
28 /100
High
Debt/Equity 84.54x
Current ratio 2.20x
Net debt/EBITDA 4.08x
Stability
50 /100
Moderate
Beta 1.24x
Rev. volatility 4.97%
Profitable years 1

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o AMRX
Online

O podjetju

Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Chirag K. Patel

Employees

8,700

Headquarters

Bridgewater

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

42d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.